Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
topic: Access to Medicines
Shortening distances: providing healthcare to indigenous communities in Venezuela’s Delta Amacuro state
Read More
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
Read More
Kenya: Everyone is welcome at MSF’s youth-friendly health services in Mombasa
Read More
MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old
Read More
Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production
Read More
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Read More
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
Read More
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug
Read More
Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
Read More
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
Read More